Stallergenes Greer in brief

Headquartered in London (UK), Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies.

Our commitment

Enable people with allergies to live
normal lives.

Focus on AIT

Rapidly growing numbers of people are affected by the allergens that are found in everyday living. Allergies to pollen, house dust mites, animal hair, food and more put boundaries on the way people live.

Press release

November 14, 2018

Stallergenes Greer Announces U.S. FDA Approval of Pediatric Indication Extension for Oralair® Sublingual Immunotherapy Tablet for the Treatment of Grass Pollen Allergy

All press releases